[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632184":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":36,"centralContacts":40,"locations":46,"responsibleParty":64,"collaborators":26,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":26,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":26,"enrollmentInfo":75,"targetDuration":26,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":88,"whyStopped":26,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Libre 3 Plus continuous glucose monitoring (CGM) system","EXPERIMENTAL","use of unmasked continuous glucose monitoring",[13],"Device: Libre 3 Plus continuous glucose monitoring (CGM) system",{"label":15,"type":16,"description":17,"interventionNames":18},"Blinded CGM and fingerstick monitoring","ACTIVE_COMPARATOR","Self-monitoring blood glucose (SMBG)+masked CGM",[19,20],"Device: Blinded Continuous Glucose Monitoring","Behavioral: Finger stick",[22,27,31],{"type":23,"name":9,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Use of unmasked CGM after discharge",[9],null,{"type":23,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Blinded Continuous Glucose Monitoring","Masked CGM",[15],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":26},"BEHAVIORAL","Finger stick","Self-monitoring blood glucose",[15],[37],{"name":38,"affiliation":5,"role":39},"Grenye O'Malley, MD","PRINCIPAL_INVESTIGATOR",[41],{"name":42,"role":43,"phone":44,"phoneExt":26,"email":45},"Sophie Baum","CONTACT","212-241-7173","sophie.baum@mssm.edu",[47],{"facility":5,"status":26,"city":48,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"New York","10035","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-74.00597,40.71427,{"lat":56,"lon":55},[59,61,62],{"name":38,"role":43,"phone":44,"phoneExt":26,"email":60},"grenye.o'malley@mssm.edu",{"name":42,"role":43,"phone":26,"phoneExt":26,"email":45},{"name":63,"role":39,"phone":26,"phoneExt":26,"email":26},"Grenye O'Malley",{"type":39,"investigatorFullName":63,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Associate Professor","100632184","cgm-after-discharge-from-hospital-100632184",false,"NCT07510386","CGM After Discharge From Hospital","Continuous Glucose Monitoring for Post-discharge Diabetes Management","Inclusion Criteria:\n\n* Adult 18 years or older.\n* Inpatient treatment for type 2 or steroid induced diabetes during hospitalization, with plan for insulin use after discharge.\n\nExclusion Criteria:\n\n* Type 1 diabetes\n* Plan for discharge to rehabilitation\u002Fskilled nursing\u002Fhospice facility\n* Contra-indication to sensor placement\n* Pregnancy","ALL","18 Years",{"count":76,"type":77},64,"ESTIMATED","INTERVENTIONAL",[80],"NA","This is an investigator initiated prospective, randomized controlled trial which aims to compare two groups of patients with either type 2 or steroid-induced diabetes who are discharged with insulin. The intervention group will use the Libre 3 Plus continuous glucose monitoring (CGM) system at discharge, while the control group will use blinded CGM and fingerstick monitoring. Both the intervention and control groups will wear the sensor for 28 days post discharge and participate in telehealth diabetes management visits. The target enrollment for the study is 65 participants and participants are expected to be in the study for up to 35 days.",[83,84],"Type 2 Diabetes","Steroid-induced Diabetes",[86,87],"discharge","CGM","NOT_YET_RECRUITING","2026-08-05",{"date":91,"type":92},"2026-08-10","ACTUAL",{"date":94,"type":77},"2026-09-30",{"date":96,"type":77},"2026-11",{"name":5,"class":6},1]